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Abstract
Background: We aimed to develop a set of quality indicators for patients with traumatic brain injury (TBI) in
intensive care units (ICUs) across Europe and to explore barriers and facilitators for implementation of these quality
indicators.
Methods: A preliminary list of 66 quality indicators was developed, based on current guidelines, existing practice
variation, and clinical expertise in TBI management at the ICU. Eight TBI experts of the Advisory Committee
preselected the quality indicators during a first Delphi round. A larger Europe-wide expert panel was recruited for
the next two Delphi rounds. Quality indicator definitions were evaluated on four criteria: validity (better
performance on the indicator reflects better processes of care and leads to better patient outcome), feasibility (data
are available or easy to obtain), discriminability (variability in clinical practice), and actionability (professionals can act
based on the indicator). Experts scored indicators on a 5-point Likert scale delivered by an electronic survey tool.
Results: The expert panel consisted of 50 experts from 18 countries across Europe, mostly intensivists (N = 24, 48%)
and neurosurgeons (N = 7, 14%). Experts agreed on a final set of 42 indicators to assess quality of ICU care: 17 structure
indicators, 16 process indicators, and 9 outcome indicators. Experts are motivated to implement this finally proposed
set (N = 49, 98%) and indicated routine measurement in registries (N = 41, 82%), benchmarking (N = 42, 84%), and
quality improvement programs (N = 41, 82%) as future steps. Administrative burden was indicated as the most
important barrier for implementation of the indicator set (N = 48, 98%).
Conclusions: This Delphi consensus study gives insight in which quality indicators have the potential to improve
quality of TBI care at European ICUs. The proposed quality indicator set is recommended to be used across Europe for
registry purposes to gain insight in current ICU practices and outcomes of patients with TBI. This indicator set may
become an important tool to support benchmarking and quality improvement programs for patients with TBI in the
future.
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Background
Traumatic brain injury (TBI) causes an enormous health
and economic burden around the world [1]. Patients
with moderate and severe TBI are at high risk for poor
outcomes and often require intensive care unit (ICU)
admission. In these patients, evidence-based treatment
options are scarce and large differences in outcome and
daily ICU practice exist [2–5].
Research to establish more evidence-based and thereby
uniform treatment policies for patients with TBI has high
priority. Still, breakthrough intervention strategies are
scarce [6] and guideline recommendations remain limited.
Therefore, new strategies, such as precision medicine and
routine quality measurement, are being explored to drive
research and clinical practice forward [1]. Routine quality
measurement using appropriate indicators can guide qual-
ity improvement, for example, through identifying best
practices and internal quality improvement initiatives. The
potential of quality indicators to improve care has already
been demonstrated in other clinical areas [7], in other
ICU populations like sepsis [8] or stroke patients [9], and
in children with TBI [10, 11].
However, there are also examples of quality indicators
that do not positively affect the quality of care. This may
be for various reasons, such as lack of validity and reliabil-
ity, poor data quality, or lack of support by clinicians [12–
14]. Deploying poor indicators has opportunity costs due
to administrative burden while distorting healthcare prior-
ities. An evaluation of a putative quality indicator is inher-
ently multidimensional, and when used to identify best
practice or benchmark hospitals, validity and reliability
and uniform definitions are all equally important [15, 16].
Although some quality indicator sets for the general
ICU exist [17, 18], there are no consensus-based quality
indicators specific for the treatment of adult patients with
TBI. Delphi studies have been proposed as a first step in
the development of quality indicators [19]. The systematic
Delphi approach gathers information from experts in dif-
ferent locations and fields of expertise to reach group con-
sensus without groupthink [19], an approach which aims
to ensure a breadth of unbiased participation.
The aim of this study was to develop a consensus-based
European quality indicator set for patients with TBI at the
ICU and to explore barriers and facilitators for implemen-
tation of these quality indicators.
Methods
This study was part of the Collaborative European
NeuroTrauma Effectiveness Research in Traumatic Brain
Injury (CENTER-TBI) project [20].
An Advisory Committee (AC) was convened, consist-
ing of 1 neurosurgeon (AM), 3 intensivists (MJ, DM,
GC), 1 emergency department physician (FL), and 3 TBI
researchers (HL, ES, LW) from 5 European countries.
The AC’s primary goals were to provide advice on the
recruitment of the Delphi panel, to monitor the Delphi
process, and to interpret the final Delphi results. During
a face-to-face meeting (September 2017), the AC agreed
that the Delphi study would initially be restricted to
Europe, recruit senior professionals as members of the
Delphi panel, and focus on the ICU. The restriction to a
European rather than a global set was motivated by sub-
stantial continental differences in health funding sys-
tems, health care costs, and health care facilities. The set
was targeted to be generalizable for the whole of Europe
and therefore included European Delphi panelists. The
AC agreed to target senior professionals as Delphi panel-
ists as they were expected to have more specialized and
extensive clinical experience with TBI patients at the ICU.
The AC decided to focus the indicator set on ICU prac-
tice, since ICU mortality rates are high (around 40% in pa-
tients with severe TBI [21]), large variation in daily
practice exists [2–5, 22], and detailed data collection is
generally more feasible in the ICU setting due to available
patient data management systems or electronic health re-
cords (EHRs). We focused on adult patients with TBI.
Delphi panel
The AC identified 3 stakeholder groups involved in ICU
quality improvement: (1) clinicians (physicians and
nurses) primary responsible for ICU care, (2) physicians
from other specialties than intensive care medicine who
are regularly involved in the care of patients with TBI at
the ICU, and (3) researchers/methodologists in TBI re-
search. It was decided to exclude managers, auditors,
and patients as stakeholders, since the completion of the
questionnaires required specific clinical knowledge. Pre-
requisites to participate were a minimum professional
experience of 3 years at the ICU or in TBI research.
Stakeholders were recruited from the personal network
of the AC (also through social media), among the princi-
pal investigators of the CENTER-TBI study (contacts
from more than 60 NeuroTrauma centers across 22
countries in Europe) [20], and from a European publica-
tion on quality indicators at the ICU [18]. These experts
were asked to provide additional contacts with sufficient
professional experience.
Preliminary indicator set
Before the start of the Delphi process, a preliminary set
of quality indicators was developed by the authors and
the members of the AC, based on international guide-
lines (Brain Trauma Foundation [23] and Trauma Qual-
ity Improvement Program guidelines [24]), ICU practice
variation [3–5], and clinical expertise (Additional file 1:
Questionnaire round 1). Quality indicators were catego-
rized into structure, process, and outcome indicators
[25]. Overall, due to the absence of high-quality evidence
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on which thresholds to use in TBI management, we
refrained from formulating quality indicators in terms of
thresholds. For example, we did not use specific carbon
dioxide (CO2) or intracranial pressure (ICP) thresholds
to define quality indicators for ICP-lowering treatments.
Indicator selection
The Delphi was conducted using online questionnaires
(Additional files 1, 2, and 3). In the first round, the AC
rated the preliminary quality indicators on four criteria:
validity, discriminability (to distinguish differences in
center performance), feasibility (regarding data collec-
tion required), and actionability (to provide clear direc-
tions on how to change TBI care or otherwise improve
scores on the indicator) [26–30] (Table 1). We used a
5-point Likert scale varying from strongly disagree (1) to
strongly agree (5). Additionally, an “I don’t know” option
was provided to capture uncertainty. Agreement was de-
fined as a median score of 4 (agreement) or 5 (strong
agreement) on all criteria. Disagreement was defined as
a median score below 4 on at least one of the four cri-
teria [31, 32]. Consensus was defined as an interquartile
range (IQR) ≤ 1 (strong consensus) on validity—since
validity is considered the key characteristic for a useful
indicator [19]—and IQR ≤ 2 (consensus) on the other
criteria [31, 32]. Criteria for rating the indicators and
definitions of consensus remained the same during all
rounds. The AC was able to give recommendations for
indicator definitions at the end of the questionnaire. In-
dicators were excluded for the second Delphi round
when there was consensus on disagreement on at least
one criterion, unless important comments for improve-
ment of the indicator definition were made. Such indica-
tors with improved definitions were rerated in the next
Delphi round.
In the second round, the remaining indicators were
sent to a larger group of experts. The questionnaire
started with a description of the goals of the study, and
some characteristics of experts were asked. Experts had
the possibility to adapt definitions of indicators at the
end of a group of indicators on a certain topic (domain).
Indicators were included in the final set when there was
agreement and consensus, excluded when there was dis-
agreement and consensus, and included the next round
when no consensus was reached or important comments
to improve the indicator definitions were given. As many
outcome scales exist for TBI, like the Glasgow Outcome
Scale - Extended (GOSE), Coma Recovery Scale - Re-
vised (CSR-R), and Rivermead Post-Concussion Symp-
toms Questionnaire (RPQ), a separate ranking question
was used to determine which outcome scales were pre-
ferred (or most important) to use as outcome indica-
tors—to avoid an extensive outcome indicator set
(Additional file 2, question outcome scales). Outcome
scales that received the highest ratings (top 3) were se-
lected for round 3 and rated as described above. Finally,
exploratory questions were asked for which goals or rea-
sons experts would implement the quality indicators.
We only selected experts for the final round that com-
pleted the full questionnaire.
In the last round, the expert panel was permitted only
to rate the indicators, but could not add new indicators
or suggest further changes to definitions. Experts re-
ceived both qualitative and quantitative information on
the rating of indicators (medians and IQRs) from round
2 for each individual indicator. Indicators were included
in the final set if there was both agreement and consen-
sus. Final exploratory questions were asked regarding
the barriers and facilitators for implementation of the in-
dicator set. For each Delphi round, three automated re-
minder emails and two personal reminders were sent to
the Delphi participant to ensure a high response rate.
Statistical analysis
Descriptive statistics (median and interquartile range)
were calculated to determine which indicators were se-
lected for the next round and to present quantitative feed-
back (median and min-max rates) in the third Delphi
round. “I don’t know” was coded as missing. A sensitivity
analysis after round 3 was performed to determine the in-
fluence of experts from Western Europe compared with
other European regions on indicator selection (in- or ex-
clusion in the final set). Statistical analyses were per-
formed using the R statistical language [33].
Questionnaires were developed using open-source Lime-
Survey software [34]. In LimeSurvey, multiple online
questionnaires can be developed (and send by email), the
response rates can be tracked, and questionnaire scores or
responses can easily be exported to a statistical program.
Results
Delphi panel
The Delphi rounds were conducted between March
2018 and August 2018 (Fig. 1). Approximately 150 ex-
perts were invited for round 2, and 50 experts from 18
Table 1 Selection criteria used to rate the quality indicators
Criteria Definition
Validity It is likely that better performance on the indicator
reflects better processes of care and leads to a better
patient outcome
Feasibility Measurement of the indicator is feasible
(data for the indicator are available or easy to obtain)
Discriminability It is expected that there is variability in clinical practice
Actionability The indicator can be used to improve quality of care,
and professionals can act on it
These criteria were used to rate each quality indicator during all Delphi
rounds [26–30]
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countries across Europe responded (≈33%). Most were
intensivists (N = 24, 48%), followed by neurosurgeons
(N = 7, 14%), neurologists (N = 5, 10%), and
anesthesiologist (N = 5, 10%) (Table 2). Most of the
experts indicated to have 15 years or more experience
with patients with TBI at the ICU or another depart-
ment (N = 25, 57%). Around half of the experts indi-
cated that they had primary responsibility for the
daily practical care of patients with TBI at the ICU
(N = 21, 47%). Experts were employed in 37 centers
across 18 European countries: mostly in Western
Europe (N = 26, 55%). Most experts were from aca-
demic (N = 37, 84%) trauma centers in an urban loca-
tion (N = 44, 98%). Almost all experts indicated the
availability of EHRs in their ICU (N = 43, 96%). Thirty-one
experts (63%) participated in the CENTER-TBI study. The
response rate in round 3 was 98% (N = 49).
Indicator selection
The first Delphi round started with 66 indicators (Fig. 1).
In round 1, 22 indicators were excluded. The main rea-
son for exclusion was poor agreement (median < 4) on
all criteria except discriminability (Additional file 4).
Round 2 started with 46 indicators; 17 were directly in-
cluded in the final set and 7 were excluded, mainly due
to a poor agreement (median < 4) on actionability and
poor consensus (IQR > 1) on validity. Round 3 started
with 40 indicators; 25 indicators were included in the
final set. Exclusion of 8 indicators was based on the sen-
sitivity analysis (no consensus in Western Europe versus
other European regions) and 7 indicators had low agree-
ment on actionability or no consensus on validity or
actionability. During the full Delphi process, 20 new in-
dicators were proposed, and 30 definitions were dis-
cussed and/or modified.
Fig. 1 Overview of the Delphi process. Overview of the Delphi
process: time frame, experts’ involvement, and indicator selection; *8
indicators were removed based on the sensitivity analyses. The left
site of the figure shows the number of indicators that were
removed after disagreement and consensus with no comments to
improve definitions. In addition, the number of changed indicator
definitions is shown. The right site of the figure shows the number
of newly proposed indicators (that were rerated in the next Delphi
round) and the number of indicators that were included in the final
indicator set. After round 2, 17 indicators were included in the final
set (and removed from the Delphi process), and after round 3, 25
indicators were included in the final set—a total of 42 indicators.
The agreement was defined as a median score of 4 (agreement) or
5 (strong agreement) on all four criteria (validity, feasibility,
discriminability, and actionability) to select indicators. The
disagreement was defined as a median score below 4 on at least
one of the four criteria. The consensus was defined as an
interquartile range (IQR) ≤ 1 (strong consensus) on validity—since
validity is considered the key characteristic for a useful indicator
[19]—and IQR ≤ 2 (consensus) on the other criteria
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Table 2 Baseline characteristics Delphi panel
Number Percent
Total number of Delphi panelists 50 100
Total number of participating centers 37 100
Gender (N = 50)
Male 40 80
Female 10 20
Profession (N = 50)
Neurosurgeon 7 14
Intensivist 24 48
Neurologist 5 10
Anesthesiologist 5 10
Trauma surgeon 2 4
Rehabilitation specialist 3 6
Methodologist/researcher in TBI 3 6
Neurophysiologist 1 2
Number of years of professional experience at the ICU a(N = 44)
3–5 years 4 9
5–10 years 8 18
10–15 years 7 16
> 15 years 25 57
Primary responsible/in charge for the daily care of patients with TBI at the ICU a(N = 45)
Yes 21 47
No 24 53
Location b(N = 50)
Northern Europe 6 12
Western Europe 28 56
UK 5 10
Southern Europe 8 16
Eastern Europe 2 4
Baltic States 1 2
Center (N = 44)
Academic 37 84
Nonacademic 7 16
Center location c(N = 45)
Urban 44 98
Suburban 1 2
Trauma designation d(N = 45)
Level I 31 69
Level II 1 2
Level III 7 15
Our center is not officially designated as a trauma center 3 7
Our country does not explicitly designate trauma centers 3 7
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The final quality indicator set consisted of 42 indicators
on 13 clinical domains (Table 3), including 17 structure in-
dicators, 16 process indicators, and 9 outcome indicators.
For the domains “precautions ICP monitoring,” “seda-
tives,” “osmotic therapies,” “seizures,” “fever,” “coagulopa-
thy,” “respiration and ventilation,” and “red blood cell
policy,” no indicators were included in the final set.
Experts proposed changing the names of the “short--
term outcomes” and “long-term outcomes” domains to
“in-hospital outcomes” and “after discharge or follow-up
outcomes.” In round 2, the Glasgow Outcome Coma Scale
Extended (GOSE), quality of life after brain injury
(Qolibri), and short form health survey (SF-36) were rated
the best outcome scales. However, the Qolibri was ex-
cluded in round 3 as an outcome indicator, since there
was no consensus in the panel on its validity to reflect the
quality of ICU care. The majority of experts (N = 14, 28%)
indicated that the outcome scales should be measured at
6months, but this was closely followed by experts that in-
dicated both at 6 and 12months (N = 13, 26%).
Barriers and facilitators for implementation
Almost all experts indicated that the indicator set should
be used in the future (N = 49, 98%). One expert did not
believe an indicator set should be used at all, because it
would poorly reflect the quality of care (N = 1, 2%).
The majority of experts indicated that the set could be
used for registry purposes (N = 41, 82%), assessment of
adherence to guidelines (N = 35, 70%), and quality im-
provement programs (N = 41, 82%). Likewise, the major-
ity of experts indicated that the indicator set could be
used for benchmarking purposes (N = 42, 84%); both
within and between centers. Pay for performance was
rarely chosen as a future goal (N = 3, 6%). Almost all
experts indicated administrative burden as a barrier
(N = 48, 98%). Overall, experts endorsed facilitators
more than the barriers for implementation (Fig. 2).
Discussion
Main findings
This three-round European Delphi study including 50
experts, resulted in a quality indicator set with 42 indica-
tors with high-level of consensus on validity, feasibility,
discriminability, and actionability, representing 13 clin-
ical domains for patients with TBI at the ICU. Experts
indicated multiple facilitators for implementation of the
total set, while the main barrier was the anticipated ad-
ministrative burden. The selection of indicators during
the Delphi process gave insight in which quality indica-
tors were perceived as important to improve the quality
of TBI care. In addition, the indicator definitions evolved
during the Delphi process, leading to a final set of
understandable and easy to interpret indicators by (clin-
ical) experts. This set serves as a starting point to gain
insight into current ICU care for TBI patients, and after
empirical validation, it may be used for quality measure-
ment and improvement.
Our Delphi resulted in 17 structure indicators, 16
process indicators, and 9 outcome indicators. A large
number of structure indicators already reached consen-
sus after round 2; this might reflect that these were more
concise indicators. However, during the rounds, defini-
tions for process indicators became more precise and
specific. Process indicators must be evidence-based
Table 2 Baseline characteristics Delphi panel (Continued)
Number Percent
Electronic patient records a(N = 45)
Yes 43 96
No 2 4
Participation in CENTER-TBI study (N = 49)
Yes 31 63
No 18 42
Level II trauma center: A level II trauma center provides comprehensive trauma care in either a population-dense area in which a level II trauma center may
supplement the clinical activity and expertise of a level I institution or occur in less population-dense areas. In the latter case, the level II trauma center serves as
the lead trauma facility for a geographic area when a level I institution is not geographically close enough to do so. It is characterized by 24-h in-house availability
of an attending surgeon and the prompt availability of other specialties (e.g., neurosurgeon, trauma surgeon). Level III trauma center: A level III trauma center has
the capacity to initially manage the majority of injured patients and have transfer agreements with a level I or II trauma center for seriously injured patients
whose needs exceed the facility’s resources
TBI traumatic brain injury, CENTER-TBI study Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury study, ICU intensive care unit
aOnly asked to those who answered clinician as a profession
bLocation is based on United Nations geoscheme: Northern Europe = Norway (1), Sweden (2), Finland (2), and Denmark (1); Western Europe = Austria(1), Belgium
(3), France (1), Germany (4), Switzerland (1), and The Netherlands (18); the UK and Ireland (5), Southern Europe = Portugal (1), Italy (5), and Spain (2); Eastern
Europe = Ukraine (1), Serbia (1); Baltic States = Latvia (1)
cUrban: an hospital location very near to a city and situated in a crowded area
Suburban: between urban and rural (an hospital location in or very near to the countryside in an area that is not crowded.)
dLevel I trauma center: A regional resource center that generally serves large cities or population-dense areas. A level I trauma center is expected to manage large
numbers of severely injured patients (at least 1200 trauma patients annually or have 240 admissions with an Injury Severity Score of more than 14). It is
characterized by 24-h in-house availability of an attending surgeon and the prompt availability of other specialties (e.g., neurosurgeon, trauma surgeon)
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Table 3 Finally proposed set of clinical quality indicators in traumatic brain injury at the ICU
Domain Indicators
Protocol
1. Structure: The existence of a protocol including specific guidelines (like the BTF guidelines or institutional guidelines) for traumatic brain
injury patients (yes/no)
2. Structure: The presence of (some form of) regular audits to check guideline adherence in general at the intensive care unit (ICU) (yes/no)
Extra: Audits do not have to be specific for TBI
3. Structure: The presence of a dedicated person(s) to oversee guidelines development and maintenance, including those for patients with
TBI, at the ICU (yes/no)
Intensive care unit
4. Structure: The presence of a step-down unit where patients can still be monitored 24/7, but less intensively than at the ICU (yes/no)
Extra: A facility in-between ICU and ward. It is often used for patients who improved at the intensive care and no longer need the intensity
of ICU care, but are also not well enough to be cared for at the ward. The care provided in step down beds is less intensive than
the care provided at the ICU but more intensive than ward care
5. Structure: Does your hospital have a dedicated/specialized neurocritical care unit? (yes/no)
6. Structure: The availability of operating rooms 24 h per day (yes/no)
7. Process: Median accident-to-ICU-admission time (process)
Extra: Time of the accident/injury to ICU-door-time
Staff
8. Structure: A daily meeting between intensivist and neurosurgeon to discuss patients with TBI at the ICU (yes/no)
9. Structure: Availability of a neurosurgeon (staff) 24/7 within 30 min after the call (yes/no)
10. Structure: Total number of disciplines (i.e., neurologist, physiotherapy, occupational therapy) involved during ICU stay
11. Structure: Certified intensivist present in person 7 days a week during at least day-time (yes/no)
12. Structure: Intensivist to ICU bed ratio
13. Structure: ICU nurse to ICU bed ratio
14. Process: Number of visits by a neurosurgeon/ total number of ICU days in patients with TBI
CT scanning
15. Structure: 24/7 availability of a CT scan and radiologist review (yes/no)
ICP monitoring
16. Structure: 24/7 availability of a certified person at your center that can insert an ICP monitor within 2 h after admission at
the ICU (yes/no)
17. Process: Number of severe (GCS 3–8) TBI patients with ICP monitoring/number of severe TBI patients at the ICU
18. Outcome: Number of EVD infections in patients with TBI/total number of patients with TBI at the ICU with an EVD inserted
Extra: Only for centers that use ventricular catheters
Deep venous thrombosis (DVT)
19. Process: Number of patients with TBI that receive any DVT prophylaxis/total number of patients with TBI at the ICU
Extra: Timing (application of prophylaxis in days from the injury) and type of DVT prophylaxis (mechanical and/or pharmaceutical) can be
registered as well
20. Process: Number of patients that receive pharmaceutical prophylaxis with low molecular weight heparins/total number of TBI patients
admitted to the ICU
Extra: This QI is about the choice of prophylaxis (low molecular weight heparin), not about timing
21. Process: Number of patients with TBI that receive mechanical DVT prophylaxis (e.g., stockings) initiated within 6 h/total number
of patients with TBI at the ICU with the possibility to receive stockings
Extra: Exclude patients with leg fractures
Glucose and nutrition
22. Structure: Do you have a protocol for glucose management available for patients with TBI at your ICU? yes/no
23. Process: Number of TBI patients with basal full caloric replacement within 5 to 7 days post-injury/number of TBI patients at the ICU
24. Process: Number of TBI patients with start of (early) enteral nutrition within 72 h/number of patients with enteral feeding during
ICU stay
25. Outcome: Number of TBI patients with any blood glucose above 10 mmol/L (180 mg/dL, hyperglycemia)/total number of patients
with TBI at the ICU
Extra: Other values are not necessarily good, only detection of extreme cases
26. Outcome: Number of TBI patients with any blood glucose below 4mmol/L (hypoglycemia)/total number of patients with TBI at the ICU
Extra: Other values are not necessarily good, only detection of extreme cases
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before best practices can be determined: this might also
explain that important domains with indicators on daily
care in TBI (such as decompressive craniectomy, os-
motic therapies, respiration, and ventilation manage-
ment) did not reach consensus in our Delphi study.
Structure, process, and outcome indicators have their
own advantages and disadvantages. For example, process
indicators tend to be inherently actionable as compared
to structure and outcome indicators, yet outcome indi-
cators are more relevant to patients [35]. Most indica-
tors were excluded from the set due to low agreement
and lack of consensus on actionability and validity: this
Table 3 Finally proposed set of clinical quality indicators in traumatic brain injury at the ICU (Continued)
Domain Indicators
Surgery
27. Structure: The presence of a protocol/institutional guideline that provide indications for surgery with SDH an EDH (yes/no)
28. Process: Median door-to-operation time for acute operation of SDH and EDH with surgical indication
Allied health professional
29. Process: Number of patients with a support plan (e.g., rehabilitation) after ICU discharge/number of patients discharged from the ICU
Extra: plan consists of physio-, speech-, and occupational therapist goals during hospital stay
30. Process: Number of patients with TBI visited daily by a physiotherapist during ICU stay/total number of patients with TBI at the ICU
Assessment scales at the ICU
31. Structure: Information on prognosis is discussed with family by one of the treating physicians (ICU physician or neurosurgical physician)
at least once during ICU stay
32. Process: Number of assessments of motor scores of the GCS/total number of ICU days in patients with TBI
33. Process: Number of assessments of pupillary responses/total number of ICU days in patients with TBI
34. Process: Number of assessments of delirium presence with validated screening tool in conscious TBI patients/total number of ICU days
in conscious TBI patients
In-hospital outcomes
35. Outcome: Number of ICU-deaths among patients with TBI/total number of ICU-admitted patients with TBI
36. Outcome: Incidence of ventilator-associated pneumonia (VAP) in patients with TBI/total number of TBI patients with mechanical
ventilation at the ICU
Extra: Pneumonia defined as “the presence of new lung infiltrate plus clinical evidence that the infiltrate is of an infectious origin, which
includes the new onset of fever, purulent sputum, leukocytosis, and a decline in oxygenation,”. VAP is defined as pneumonia occurring
> 48 h after endotracheal intubation [46]
37. Outcome: Number of TBI patients with decubitus grade 2 or higher at the ICU/number of TBI patients at the ICU
Extra (also register the grade): Grade 1: Pressure zone with redness that does not blanch with fingertip pressure, with the skin still intact
Grade 2: Decubitus ulcer (pressure sore) with skin erosion, blister, partial loss of the epidermis and/or dermis, or skin loss
Grade 3: Decubitus ulcer (pressure sore) with loss of all skin layers and damage or necrosis of the subcutaneous tissue, which may extend
down to the underlying fascia
Grade 4: Decubitus ulcer (pressure sore) with necrosis of the muscle, bone, or supportive structures such as tendons or joint capsules
38. Outcome: Number of patients with TBI with severe sepsis or septic shock/total number of patients with TBI at the ICU
Extra: Sepsis should be defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. For clinical
operationalization, organ dysfunction can be represented by an increase in the Sequential [sepsis-related] Organ Failure
Assessment (SOFA) score of 2 points or more, which is associated with an in-hospital mortality greater than 10%. The septic shock
should be defined as a subset of sepsis in which particularly profound circulatory, cellular, and metabolic abnormalities are associated
with a greater risk of mortality than with sepsis alone. Patients with septic shock can be clinically identified by a vasopressor requirement
to maintain a mean arterial pressure of 65 mmHg or greater and serum lactate level greater than 2 mmol/L (> 18 mg/dL) in the absence
of hypovolemia [47]
After discharge or follow-up outcomes
39. Process: Number of patients with TBI receiving follow-up by a specialist within 2 months after discharge/total number of patients with
TBI discharged (not in rehab clinic)
40. Process: Number of patients with neuropsychological testing at hospital discharge/number of patients with TBI discharged from the
hospital
Outcome scales at 6 months
41. Outcome: The median score of the GOSE from all patients with TBI at 6 months/number of patients with TBI discharged from the ICU
and alive at 6 months
42. Outcome: The median score of the SF-36 from all patients with TBI at 6 months/number of patients with TBI discharged from the ICU
and alive at 6 months
The final set of indicators after the Delphi rounds per domain. All outcome indicators will be adjusted for case-mix
EDH epidural hematoma, GCS Glasgow Coma Scale, GOSE Glasgow Coma Scale – Extended, ICU intensive care unit SDH subdural hematoma,
SF-36 36-item short form survey
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indicates that experts highly valued the practicality and
usability of the set and were strict on selecting only
those indicators that might improve patient outcome
and processes of care. Overall, the complete set com-
prises all different types of indicators.
Existing indicators
Some national ICU registries already exist [17], and in
2012, a European ICU quality indicator set for general
ICU quality has been developed [18]. In addition, several
trauma databanks already exist [36, 37]. The motivations
for selection (or rejection) of indicators in our study can
contribute to the ongoing debate on which indicators to
collect in these registries. For example, length of stay is
often used as an outcome measure in current registries,
but the Delphi panel commented that determination of
the length of stay is debatable as an indicator, since hos-
pital structures differ (e.g., step-down units are not stand-
ard), and admission length can be confounded by (ICU)
bed availability. Although general ICU care is essential for
TBI, not all general ICU or trauma indicators are applic-
able in exactly the same way for TBI. For example, indi-
vidualized deep venous thrombosis prophylaxis
management in TBI is a priority in view of the risk of pro-
gressive brain hemorrhage in contrast to other ICU condi-
tions (e.g., sepsis). Therefore, our TBI-specific indicator
set might form a useful addition to current registries.
Strength and limitations
This study has several strengths and limitations. No firm
rules exist on how to perform a Delphi study in order to
develop quality indicators [19]. Therefore, we extensively
discussed the methodology and determined strategies
with the Advisory Committee. Although the RAND/
UCLA Appropriateness Method recommends a panel
meeting [38], no group discussion took place in our
study to avoid overrepresentation of strong voices and
for reasons of feasibility. However, experts received both
qualitative and quantitative information on the rating of
indicators to gain insight into the thinking process of
the other panel members. Considering the preliminary
indictor set, we used the guidelines [23, 24] as a guide to
which topics should be included and not as an evidence
base. Considering the Delphi panel, the success of indi-
cator selection depends on the expertise of invited mem-
bers: we assembled a large network of 50 experts from
18 countries across Europe with various professional
backgrounds. All participants can be considered as
established experts in the field of TBI-research and/or
daily clinical practice (around 70% of experts had more
than 10 years of ICU experience). However, more input
from some key stakeholders in the quality of ICU care,
such as rehabilitation physicians, nurses and allied health
practitioners, health care auditors, and TBI patients,
would have been preferable. We had only three rehabili-
tation experts on our panel, but increased input from
this group of professionals would have been valuable,
since they are increasingly involved in the care of pa-
tients even at the ICU stage. A number of nurses were
invited, but none responded, possibly due to a low invi-
tation rate. This is a severe limitation since nurses play a
key role in ICU quality improvement and quality
Fig. 2 Facilitators or barriers for implementation of the quality indicator set. Percentage of experts that indicated a certain facilitator or barrier for
implementation of the quality indicator set. Other indicated facilitator was “create meaningful uniform indicators.” Other indicated barriers were
“gaming” (N = 1, 2%) and “processes outside of ICU (e.g., rehabilitation) are hard to query.” *Participation in trauma quality improvement program
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indicator implementation [39, 40]. Therefore, future
studies should put even more efforts in involving nurses
in quality indicator development. Experts were predom-
inantly from Western Europe. Therefore, we performed
sensitivity analyses for Western Europe and removed in-
dicators with significant differences compared with other
regions to obtain a set generalizable for Europe. The re-
striction to a European rather than a global set was mo-
tivated by substantial continental differences in health
funding systems, health care costs, and health care facil-
ities. Finally, some of the responses may have been
strongly influenced by familiarity with measures (e.g.,
SF-36 was selected instead of Qolibri) rather that solely
reflecting the value of the measure per se.
Use and implementation
Quality indicators may be used for the improvement of
care in several ways. First, registration of indicator data
itself will make clinicians and other stakeholders aware
of their center or ICU performance, as indicators will
provide objective data on care instead of perceived care.
Second, as the evidence base for guidelines is often lim-
ited, this indicator set could support refinement of
guideline recommendations. This was shown in a study
by Vavilala et al., where guideline-derived indicators for
the acute care of children with TBI were collected from
medical records and were associated with improved out-
come [10]. Third, quality indicators can be used to guide
and to inform quality improvement programs. One study
showed that a TBI-specific quality improvement pro-
gram was effective, demonstrating lower mortality rates
after implementation [41]. Fourth, (international) bench-
marking of quality indicators will facilitate discussion be-
tween (health care) professionals and direct attention
towards suboptimal care processes [17]. Future bench-
marking across different hospitals or countries requires
advanced statistical analyses such as random effect re-
gression models to correct for random variation and
case-mix correction. To perform such benchmarking,
case-mix variables must be collected, like in general ICU
prognostic models or the TBI-specific prognostic
models, such as IMPACT and CRASH [42, 43].
A quality indicator set is expected to be dynamic: on-
going large international studies will further shape the
quality indicator set. This is also reflected in the “retire-
ment” of indicators over time (when 90–100% adherence
is reached). Registration and use of the quality indicators
will provide increasing insight into their feasibility and
discriminability and provides the opportunity to study
their validity and actionability. Such empirical testing of
the set will probably reveal that not all indicators meet
the required criteria and thus will reduce the number of
indicators in the set, which is desirable, as the set is still
quite extensive. For now, based on the dynamic nature of
the set and ongoing TBI studies, we recommend to use
this consensus-based quality indicator for registry pur-
poses—to gain insight (over time) in current care and not
for changing treatment policies. Therefore, we recommend
to regard this consensus-based quality indicator set as a
starting point in need of further validation, before broad
implementation can be recommended. Such validation
should seek to establish whether adherence to the quality
indicators is associated with better patient outcomes.
To provide feedback on clinical performance, new in-
terventions are being explored to further increase the ef-
fectiveness of indicator-based performance feedback,
e.g., direct electronic audit and feedback with suggested
action plans [44]. A single (external) organization for
data collection could enhance participation of multiple
centers. International collaborations must be encouraged
and further endorsement by scientific societies seems
necessary before large-scale implementation is feasible.
When large-scale implementation becomes global, there
is an urgent need to develop quality indicators for
low-income countries [36, 45]. An external organization
for data collection could also reduce the administrative
burden for clinicians. This is a critical issue, since ad-
ministrative burden was indicated as the main barrier
for implementation of the whole indicator set, although
experts agreed on the feasibility of individual indicators.
In the future, automatic data extraction might be the so-
lution to overcome the administrative burden.
Conclusion
This Delphi consensus study gives insight in which quality
indicators have the potential to improve quality of TBI care
at European ICUs. The proposed quality indicator set is
recommended to be used across Europe for registry pur-
poses to gain insight in current ICU practices and out-
comes of patients with TBI. This indicator set may become
an important tool to support benchmarking and quality
improvement programs for patients with TBI in the future.
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